| pubmed-article:1876672 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C0026549 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:1876672 | lifeskim:mentions | umls-concept:C0092897 | lld:lifeskim |
| pubmed-article:1876672 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1876672 | pubmed:dateCreated | 1991-9-26 | lld:pubmed |
| pubmed-article:1876672 | pubmed:abstractText | Rats treated subcutaneously for 6 days with morphine developed a weak tolerance which was characterized by a decrease in the analgesic action of the opioid. Under those experimental conditions a simultaneous intracerebroventricular application of 2-deoxy-D-galactose enhanced development of morphine tolerance, while other deoxy-sugars like 2-deoxy-D-glucose and 6-deoxy-D-galactose were ineffective. In contrast, no influence of 2-deoxy-D-galactose on a more enhanced morphine tolerance after a 11-day pretreatment with morphine was found. The results are discussed in the light of a rather specific interference of 2-deoxy-D-galactose with neuronal glycoprotein processing and related cellular mechanism underlying adaptive processes involved in the development of morphine tolerance. | lld:pubmed |
| pubmed-article:1876672 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1876672 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1876672 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1876672 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:RichterPP | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:MatthiesHH | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:PohleWW | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:JorkRR | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:GreckschGG | lld:pubmed |
| pubmed-article:1876672 | pubmed:author | pubmed-author:SmallaK HKH | lld:pubmed |
| pubmed-article:1876672 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1876672 | pubmed:volume | 104 | lld:pubmed |
| pubmed-article:1876672 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1876672 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1876672 | pubmed:pagination | 279-83 | lld:pubmed |
| pubmed-article:1876672 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:meshHeading | pubmed-meshheading:1876672-... | lld:pubmed |
| pubmed-article:1876672 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1876672 | pubmed:articleTitle | Enhanced development of morphine tolerance in rats treated with 2-deoxy-D-galactose. | lld:pubmed |
| pubmed-article:1876672 | pubmed:affiliation | Institute of Neurobiology and Brain Research, Magdeburg, Federal Republic of Germany. | lld:pubmed |
| pubmed-article:1876672 | pubmed:publicationType | Journal Article | lld:pubmed |
